Suven Life Sciences Ltd (SUVEN) — Announcement | 28 September 2026
Suven Life Sciences announced that its trading window will close on 1 October 2026, remaining shut for 48 hours after the unaudited Q2 results release for September 30, 2026, as mandated by SEBI insider trading rules.
About Suven Life Sciences Ltd (SUVEN)
Healthcare · Healthcare · Listed on BSE
📡 Get AI alerts when SUVEN files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track SUVEN — Free💡 Ask AI about this filing
📊 More SUVEN filings
- 🔴 Announcement — 3 September 2026Suven Life Sciences announced completion of patient enrollment in its global Phase-3 Masupirdine tri...
- Announcement — 11 August 2026Suven Life Sciences disclosed a CRISIL Monitoring Agency Report for the quarter ended June 30, 2026,...
- 🟡 Board Meeting — 6 August 2026Suven Life Sciences announced unaudited standalone and consolidated financial results for Q1 FY2026,...
- 🔴 Annual Report — 30 July 2026Suven Life Sciences held its 37th Annual General Meeting on August 25, 2026 via video conference, ap...
- 🔴 Annual Report — 30 July 2026Suven Life Sciences disclosed that its FY2025-26 Annual Report is accessible via its website at http...
🔥 Also filed on 28 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when SUVEN files new disclosures
Track SUVEN filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track SUVEN — FreeFree account · 2 AI queries/day